ASSAY RECORD
Results
Showing up to 20 records.
| NO. | RECORD ID | NAME | SEQUENCE | SOURCE ORGANISM | FUNCTION CATEGORY | TARGET ORGANISM | ACTIVITY | ASSAY METHOD | PMID | PATENT NO | VERIFICATION STATUS |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 420261 | Rec_0424703 | EKL3P |
LDLEYEMKKLEEAIKKLEESYIDLKELGTYEYYVKWGSGK |
synthetic construct [Synthetic] |
Antimicrobial, Anti-SARS-CoV-2 |
SARS-CoV-2 pseudovirus; 293T/ACE2 cells |
5 μM | IC50 |
34367893 | - |
YES |
| 420262 | Rec_0424704 | Unnamed |
QFFCPDSENDPLNCVETMATTAMCMQSKKDKSYSYACGYCGKKKESCFGDKVPVTDYNCKSRKIVNPCGGPAL |
not reported [other] |
Toxin-related activity |
- |
- | - |
39514414 | - |
NO |
| 420263 | Rec_0424705 | Apidaecin-1B [R18NLe] |
GNNRPVYIPQPRPPHPRX |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Bacillus subtilis DSM 347 |
125 μg/mL | MIC |
20560644 | - |
YES |
| 420264 | Rec_0424706 | Nisin-P |
VXXKXLXXPGXKXGILMXXAIKXAXXGXHFG |
Streptococcus agalactiae DPC7040 [Bacterium] |
Antimicrobial, Antibacterial |
Lactobacillus gallinarum Lac 43 |
8.5 μM | MIC |
32111904 | - |
YES |
| 420265 | Rec_0424707 | lysozyme (EC 3.2.1.17) |
MKFSLSVVGCALLFTAGLSNACHGPGEGGNCSIRAKVDIDGRAEPNVDSKRIPNVYKKGDCIKVRCQATGDEIYGSSIWDFDGKYYLPDHYVKTGYDGFDPHIKRCRSTPPPPVGEGCGGHLNAKGLSLIKELEGWNATFYDDGRDKFTIGYGHNCDADSTHCANIHPPISKAEGESLLKQDVSGFEKYVCKTVVHDLKCPLNCNQFGALVSFVYNVGTSPNGFPRSKLYEDLANNCNYKATSNDWTSSFTNGGDLVNRRKKELTLWSTATTSKSGC |
Absidia repens [other] |
Antimicrobial, Bacteriolytic enzyme, Hydrolase, Non-hemolytic |
- |
- | - |
- | - |
NO |
| 420266 | Rec_0424708 | Amphipathic-2d |
LLKKLLKLLLKLLKK |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Staphylococcus haemolyticus I-10925 |
1 μM | MIC |
15019200;12110678;14729742 | - |
YES |
| 420267 | Rec_0424709 | LL-III/12 |
VNWKKILGKIIKVVK |
synthetic construct [Synthetic] |
Antimicrobial, Anticancer, Hemolytic |
Rat erythrocytes |
200 μM | IC50 |
22100226 | - |
YES |
| 420268 | Rec_0424710 | Unnamed |
AALNRRIQLLEEDLE |
not reported [other] |
Immunomodulatory, Anti-inflammatory |
- |
- | - |
39514414 | - |
NO |
| 420269 | Rec_0424711 | Autolysin |
MAISVRQKLVDSSKYSLKCPNTMTAEYITIHNTYNDASANNEVQYMITNSNATSFHFAVDDFEVVQGIPTNRNAWHCGDGTGNGNMKSIGIEICYSLSGGDRYRKAEALAVKFTAQLLRERGWGISRVKKHQDWSGKYCPHRILAEGRWQSFLNAVQTELNGGGTTQPPTSTTGVVKVVTTGLNLRTQPSASAPIIRQLGYGETYEFWAISNGWYNLGGDQWAYGDNGNYLQVISGGSIAPTPAPQPKPVTGTAYITGYNVNLRSGAGTGYSVIRQLNAPESYKVWALKDGWLNLGGDQWIKNDSSFVRFVQD |
Bacillus phage vB_BanS-Tsamsa [Virus] |
Antimicrobial, Bacteriolytic, Non-hemolytic, Non-ribosomal |
- |
- | - |
24475065 | - |
NO |
| 420270 | Rec_0424712 | 2a |
CFETLRGEERILSILRHQNLLKELQD |
synthetic construct [Synthetic] |
Antimicrobial, Anticancer, Hemolytic |
- |
- | - |
36594095 | - |
YES |
| 420271 | Rec_0424713 | H-S1 |
KAWKAAK |
synthetic construct [Synthetic] |
Hemolytic |
human red blood cells |
100.0 μM | Hemolysis |
- | - |
YES |
| 420272 | Rec_0424714 | Unnamed |
GFCWHVCARRNGVRVCYRRCN |
synthetic construct [Synthetic] |
Antimicrobial |
- |
- | - |
- | US 2011/0306750 A1 |
NO |
| 420273 | Rec_0424715 | RA1 |
AEMIDLAAKMLSEGRG |
Oryza sativa subsp. Japonica [Plant] |
Immunomodulatory |
- |
- | - |
20434883 | - |
YES |
| 420274 | Rec_0424716 | Unnamed |
FAIKWEYVLLLFLL |
not reported [other] |
Antiviral, Antimicrobial |
- |
- | - |
24285301 | - |
YES |
| 420275 | Rec_0424717 | Clavaspirin [I5,12K], CSP-2 |
FKRFKGSVKHGKGHLVHHIGVAL |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Bacillus subtilis |
- | Qualitative antimicrobial assay |
29643997 | - |
YES |
| 420276 | Rec_0424718 | Ac-SS-14W |
KAAKAAKKAAKAAWK |
synthetic construct [Synthetic] |
Hemolytic |
human red blood cells |
25 μM | Hemolysis |
26235946 | - |
YES |
| 420277 | Rec_0424719 | Peptidoglycan hydrolase |
MHKKQSNDQYLHYKMYKSGRKWVFAGVAALTLLTTTEVAHADTTSSSAASTVSLNGSTVASEAAKATVTFISESTSATSSSSSTASSSSSATSASSSSVATAATSVTSATSATSATSVSSTSTDSSASAATSSDDASSSASAADANSGVSSASAATSATSASSTTVVRAVVAVATSASASSSSVDLSTLTFSNNASQQAFIESVAEGAIEGWNEYGVLPSITVAQAILESGWGSSTLSTQAHNLFGIKGSYNGNYVTMSTREVINGQSVYVNAAFRAYANNSESVEDHGNFLYSNSRYSNLLGDTSYTDVAQKLSQDGYATDPYYSSSLISLVKTYDLTQLDSIAIANTPVITNKSDYTQTNNGASTTATATYYTVQSGDTLSGIAVEYNTTTATLTSLNNLSNPNLIYVGQRLLVKSASTAAASSATSTATSTASATSTSSTTSATTYTVKSGDTLSSIASSHNTTTAALTSLNSLANPNLIYVGQVLKLANTTTASTSSTSSAASTSSSAMTYTVKSGDTLSSIASSYNTTTSTLTSLNNLSNPNLIYVGQVLKVAGSSTSVSTSTSSSSASQATTSGTYTVKAGDTLSSIASSYNTTTAALASANSISNANLIYVGQVLKVTGTSSSTSTTTSSTSSTSGSYTVKSGDSLSAIAAAHGLNWKTLAAKNNIASPYVIYVGQQLSL |
Limosilactobacillus fermentum [Bacterium] |
Antimicrobial, Bacteriolytic enzyme, Non-hemolytic |
- |
- | Qualitative functional evidence |
- | - |
NO |
| 420278 | Rec_0424720 | Insulin-like growth factor I |
GPETLCGAELVDALQFVCGDRGFYFNKPTGYGSSSRRAPQTGIVDECCFRSCDLRRLEMYCAPLKPAKSA |
Cavia porcellus [Animal] |
Hormone, Endocrine, Neuropeptide, Neuromodulator, Metabolic regulation, Physiological regulation, Growth regulation, Development regulation, Receptor modulation |
integrins and subsequent ternary complex formation with integrins and IGFR1 are essential for IGF1 signaling |
- | - |
11145579 | - |
NO |
| 420279 | Rec_0424721 | Unnamed |
AQAVKXWMTETLXVA |
synthetic construct [Synthetic] |
Antiviral, Anti-HIV |
HIV-1 IIIB |
7.97 ± 1.03 μM | IC50 |
- | US 20090281041 |
YES |
| 420280 | Rec_0424722 | Periviscerokinin-22 |
GSSGLISMPRV |
Periplaneta americana [Animal] |
Neuropeptide, Neuromodulator, Myotropic |
- |
- | - |
15626499;19257902 | - |
YES |